181 related articles for article (PubMed ID: 4905646)
1. The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella.
Ornellas EP; Roantree RJ; Steward JP
J Infect Dis; 1970 Feb; 121(2):113-23. PubMed ID: 4905646
[No Abstract] [Full Text] [Related]
2. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
Jazani NH; Worobec E; Shahabi S; Nejad GB
Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894
[TBL] [Abstract][Full Text] [Related]
3. Reagins from orally immunized animals. I. Nature and protection effect.
Levanon Y; Rossetini SM
Prog Immunobiol Stand; 1970; 4():347-51. PubMed ID: 4098271
[No Abstract] [Full Text] [Related]
4. Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.
Ramachandran G; Boyd MA; MacSwords J; Higginson EE; Simon R; Galen JE; Pasetti MF; Levine MM; Tennant SM
Clin Vaccine Immunol; 2016 Jun; 23(6):520-523. PubMed ID: 27030587
[TBL] [Abstract][Full Text] [Related]
5. Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing.
Goh YS; MacLennan CA
J Immunol Methods; 2013 Jan; 387(1-2):121-9. PubMed ID: 23085530
[TBL] [Abstract][Full Text] [Related]
6. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium.
Nnalue NA
J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129
[TBL] [Abstract][Full Text] [Related]
7. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
8. Immunization of mice and guinea-pigs against Salmonella dublin infection with live and inactivated vaccine.
Cameron CM; Fuls WJ
Onderstepoort J Vet Res; 1975 Jun; 42(2):63-9. PubMed ID: 1107926
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains.
Dehghani B; Rasooli I; Gargari SL; Nadooshan MR; Owlia P; Nazarian S
Microbiol Res; 2013 Feb; 168(2):84-90. PubMed ID: 23141708
[TBL] [Abstract][Full Text] [Related]
10. Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice.
Porta A; Morello S; Granata I; Iannone R; Maresca B
FEBS J; 2014 Nov; 281(22):5043-53. PubMed ID: 25208333
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of the stability of avirulent properties and the immunogenicity of suppressor revertants of streptomycin-dependent salmonella mutants].
Shuster BIu; Likhoded VG
Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):40-4. PubMed ID: 797191
[TBL] [Abstract][Full Text] [Related]
12. Live bacterial vaccines and their application as carriers for foreign antigens.
Dougan G; Smith L; Heffron F
Adv Vet Sci Comp Med; 1989; 33():271-300. PubMed ID: 2648775
[No Abstract] [Full Text] [Related]
13. A conditionally lethal mutant of Salmonella Typhimurium induces a protective response in mice.
Hidalgo AA; Villagra NA; Jerez SA; Fuentes JA; Mora GC
Biochem Biophys Res Commun; 2016 Feb; 470(2):313-318. PubMed ID: 26792728
[TBL] [Abstract][Full Text] [Related]
14. Intracellular pathogens: the role of antibody-mediated protection in Salmonella infection.
Eisenstein TK
Trends Microbiol; 1998 Apr; 6(4):135-6. PubMed ID: 9587189
[No Abstract] [Full Text] [Related]
15. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.
Uren TK; Wijburg OL; Simmons C; Johansen FE; Brandtzaeg P; Strugnell RA
Eur J Immunol; 2005 Jan; 35(1):180-8. PubMed ID: 15593123
[TBL] [Abstract][Full Text] [Related]
16. Experimental salmonellosis: differential passive transfer of immunity with serum and cells obtained from ribosomal and ribonucleic acid-immunized mice.
Venneman MR; Berry LJ
J Reticuloendothel Soc; 1971 May; 9(5):491-502. PubMed ID: 4933607
[No Abstract] [Full Text] [Related]
17. Recombinant-attenuated Salmonella vaccines modified to reduce virulence.
Constable L
Expert Rev Vaccines; 2011 Aug; 10(8):1117. PubMed ID: 21961199
[No Abstract] [Full Text] [Related]
18. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis.
Na HS; Kim HJ; Lee HC; Hong Y; Rhee JH; Choy HE
Vaccine; 2006 Mar; 24(12):2027-34. PubMed ID: 16356600
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of R factor-carrying Salmonella.
Jarolmen H; Hewel D; Kain E
Infect Immun; 1971 Sep; 4(3):274-80. PubMed ID: 4949492
[TBL] [Abstract][Full Text] [Related]
20. Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody.
Siggins MK; Cunningham AF; Marshall JL; Chamberlain JL; Henderson IR; MacLennan CA
J Immunol; 2011 Feb; 186(4):2365-71. PubMed ID: 21217014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
